查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球胃腸道治療藥物市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測
市場調查報告書
商品編碼
1305288

全球胃腸道治療藥物市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global Gastrointestinal Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 350 Pages | 商品交期: 最快1-2個工作天內

價格

據預測，到2030年，全球胃腸道治療藥物市場需求將從2022年的488.6億美元增至803.8億美元，2023-2030年的複合年成長率為6.42%。

胃腸道治療藥物可治療胃腸道疾病，即影響結腸、小腸、大腸和直腸的消化系統問題。這種胃腸道慢性炎症性疾病主要影響結腸粘膜。便秘、消化性潰瘍病和大腸急躁症是最常見的疾病，症狀包括不適、腹脹、腹瀉、噁心和嘔吐。胃腸道治療藥物包括Aciphex、Afinitor、akynzeo、deficit和Prilosec等市售藥物。

市場動態：

胃腸道疾病發病率的上升也提高了對胃腸道治療藥物的需求，以改善醫療服務，改變生活方式，提高工業化和衛生水準，這將促進市場成長。許多研發機構正在研究新的治療方法，預計這將推動胃腸道治療市場的擴張。由於越來越多的臨床研究結果可靠，以及醫療保健支出的增加，胃腸道治療藥物的市場正在擴大。老齡化人口不斷增加，這將加速市場擴張，因為他們更容易出現此類健康問題。然而，胃腸道治療藥物的市場擴張可能會受到相關療法和藥物的副作用以及政府對藥物審批的嚴格限制的阻礙。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球胃腸道治療藥物市場的各個細分市場進行了全面評估。胃腸道治療藥物行業的成長和趨勢為本研究提供了整體方法。

市場細分：

胃腸道治療藥物市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按類型

  • 品牌藥
  • 學名藥

按藥物類別

  • 氨基水楊酸鹽
  • 消化酶
  • 質子泵抑製劑
  • 瀉藥
  • 抗化妝品
  • H2拮抗劑
  • 止瀉藥
  • 生物製劑/生物類似藥
  • 其他

按給藥途徑

  • 口服
  • 注射劑
  • 其他

按應用分類

  • 克隆氏症
  • 潰瘍性結腸炎
  • 胃腸病
  • 大腸急躁症
  • 其他

按銷售管道

  • 醫院藥房
  • 零售藥店
  • 網上藥店

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區胃腸道治療藥物市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場中主要企業的綜合概況以及全球競爭格局的深入分析。胃腸道治療藥物市場的主要參與者包括艾伯維公司、阿斯利康公司、楊森製藥公司、太陽製藥工業有限公司、武田藥品株式會社、Salix製藥公司、輝瑞公司、拜耳公司、雅培公司、Cipla公司、吉利德科學公司、百健公司、Organon集團公司。本部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可以根據您的需求提供客製化報告。

目 錄

第一章：前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：胃腸道治療藥物-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按藥物類別的市場吸引力分析
    • 按給藥途徑的市場吸引力分析
    • 市場吸引力分析：按應用
    • 市場吸引力分析：按銷售管道
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：Covid-19爆發的影響分析

第六章：全球胃腸道治療藥物市場分析：按類型分類

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 品牌藥
  • 學名藥

第七章：全球胃腸道治療藥物市場分析：按藥物類別分類

  • 按藥物類別概述
  • 歷史和預測數據
  • 按藥物類別分析
  • 氨基水楊酸鹽
  • 消化酶
  • 質子泵抑製劑
  • 瀉藥
  • 抗化妝品
  • H2拮抗劑
  • 止瀉藥
  • 生物製劑/生物類似藥
  • 其他

第八章：全球胃腸道治療藥物市場分析：按給藥途徑分類

  • 給藥途徑概述
  • 歷史和預測數據
  • 按給藥途徑分析
  • 口服
  • 注射劑
  • 其他

第九章：全球胃腸道治療藥物市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 克隆氏症
  • 潰瘍性結腸炎
  • 胃食道逆流病
  • 大腸急躁症
  • 其他

第10章：全球胃腸道治療藥物市場分析：按銷售管道分類

  • 配銷通路概述
  • 歷史和預測數據
  • 按銷售管道分析
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第十一章：全球胃腸道治療藥物市場分析：按地域分類

  • 頂級公司佔有率分析
  • 公司簡介
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美地區銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區各細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲各細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東及非洲其他地區銷售分析

第十二章：胃腸道治療藥物公司的競爭格局

  • 胃腸道治療藥物市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第十三章：公司概況

  • 公司佔有率分析
  • 市場集中度
  • AbbVie Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • AstraZeneca
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Janssen Pharmaceuticals NV
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Sun Pharmaceutical Industries Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Takeda Pharmaceutical Company Limited
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Salix Pharmaceuticals
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Pfizer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bayer AG
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Abbott
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Cipla Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Gilead Sciences Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Biogen
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Organon Group of Companies
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

Product Code: VMR112110049

The global demand for Gastrointestinal Therapeutics Market is presumed to reach the market size of nearly USD 80.38 BN by 2030 from USD 48.86 BN in 2022 with a CAGR of 6.42% under the study period 2023 - 2030.

Gastrointestinal therapeutics treats gastrointestinal disorders, which are digestive system issues affecting the colon, small and large intestines, and rectum. This chronic inflammatory illness of the gastrointestinal tract mainly affects the colon's mucosal lining. Constipation, peptic ulcer diseases, and irritable bowel syndrome are the most common conditions, with symptoms such as discomfort, bloating, diarrhoea, nausea, and vomiting. Gastrointestinal therapeutics include commercially accessible medication such as Aciphex, Afinitor, akynzeo, deficit, and Prilosec.

Market Dynamics:

The rising prevalence of gastrointestinal disorders is also raising demand for gastrointestinal therapeutics to enhance better healthcare access, to change lifestyles, and for higher rates of industrialization and sanitation, which will increase the market growth. Numerous R&D organizations are investigating new therapeutic modalities, which are anticipated to boost the market expansion of gastrointestinal therapeutics. The market for gastrointestinal therapeutics is expanding due to more clinical studies with reliable outcomes and rising healthcare expenditure. The ageing population is growing, which will accelerate market expansion because they are more prone to such health problems. However, the market expansion of gastrointestinal therapeutics can be hampered by related side effects of therapies and medication and strict governmental restrictions for drug approval.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gastrointestinal therapeutics. The growth and trends of gastrointestinal therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the gastrointestinal therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Branded
  • Generics

By Drug Class

  • Aminosalicylates
  • Digestive Enzymes
  • Proton Pump Inhibitors
  • Laxatives
  • Anti-Emetics
  • H2 Antagonists
  • Anti-Diarrheal
  • Biologics/Biosimilar
  • Others

By Route Of Administration

  • Oral
  • Injectable
  • Others

By Application

  • Crohn'S Disease
  • Ulcerative Colitis
  • Gerd
  • IBS
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Gastrointestinal Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gastrointestinal therapeutics market include AbbVie Inc., AstraZeneca, Janssen Pharmaceuticals NV, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Salix Pharmaceuticals, Pfizer Inc., Bayer AG, Abbott, Cipla Inc., Gilead Sciences Inc., Biogen, Organon Group of Companies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GASTROINTESTINAL THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Branded Historic and Forecast Sales by Regions
  • 6.5 Generics Historic and Forecast Sales by Regions

7 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 7.1 Overview by Drug Class
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Drug Class
  • 7.4 Aminosalicylates Historic and Forecast Sales by Regions
  • 7.5 Digestive Enzymes Historic and Forecast Sales by Regions
  • 7.6 Proton Pump Inhibitors Historic and Forecast Sales by Regions
  • 7.7 Laxatives Historic and Forecast Sales by Regions
  • 7.8 Anti-Emetics Historic and Forecast Sales by Regions
  • 7.9 H2 Antagonists Historic and Forecast Sales by Regions
  • 7.10. Anti-Diarrheal Historic and Forecast Sales by Regions
  • 7.11 Biologics/Biosimilar Historic and Forecast Sales by Regions
  • 7.12 Others Historic and Forecast Sales by Regions

8 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1 Overview by Route Of Administration
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Route Of Administration
  • 8.4 Oral Historic and Forecast Sales by Regions
  • 8.5 Injectable Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Crohn's Disease Historic and Forecast Sales by Regions
  • 9.5 Ulcerative Colitis Historic and Forecast Sales by Regions
  • 9.6 GERD Historic and Forecast Sales by Regions
  • 9.7 IBS Historic and Forecast Sales by Regions
  • 9.8 Others Historic and Forecast Sales by Regions

10 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 10.1 Overview by Distribution Channel
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Distribution Channel
  • 10.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 10.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 10.6 Online Pharmacies Historic and Forecast Sales by Regions

11 . GLOBAL GASTROINTESTINAL THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GASTROINTESTINAL THERAPEUTICS COMPANIES

  • 12.1. Gastrointestinal Therapeutics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF GASTROINTESTINAL THERAPEUTICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. AbbVie Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. AstraZeneca
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Janssen Pharmaceuticals NV
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Sun Pharmaceutical Industries Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Takeda Pharmaceutical Company Limited
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Salix Pharmaceuticals
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Pfizer Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Bayer AG
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Abbott
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Cipla Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Gilead Sciences Inc.
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Biogen
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. Organon Group of Companies
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Branded Market Sales by Geography (USD MN)
  • Generics Market Sales by Geography (USD MN)
  • Analysis Market by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Digestive Enzymes Market Sales by Geography (USD MN)
  • Proton Pump Inhibitors Market Sales by Geography (USD MN)
  • Laxatives Market Sales by Geography (USD MN)
  • Anti-Emetics Market Sales by Geography (USD MN)
  • H2 Antagonists Market Sales by Geography (USD MN)
  • Anti-Diarrheal Market Sales by Geography (USD MN)
  • Biologics/Biosimilar Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • GERD Market Sales by Geography (USD MN)
  • IBS Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Gastrointestinal Therapeutics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gastrointestinal Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Gastrointestinal Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Branded Market Sales by Geography (USD MN)
  • Generics Market Sales by Geography (USD MN)
  • Global Market Analysis by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Digestive Enzymes Market Sales by Geography (USD MN)
  • Proton Pump Inhibitors Market Sales by Geography (USD MN)
  • Laxatives Market Sales by Geography (USD MN)
  • Anti-Emetics Market Sales by Geography (USD MN)
  • H2 Antagonists Market Sales by Geography (USD MN)
  • Anti-Diarrheal Market Sales by Geography (USD MN)
  • Biologics/Biosimilar Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • GERD Market Sales by Geography (USD MN)
  • IBS Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.